Skip to content

Skills to Enhance Positivity in Suicidal Youth

Skills to Enhance Positivity in Adolescents at Risk for Suicide

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04994873
Acronym
STEP
Enrollment
216
Registered
2021-08-06
Start date
2021-10-04
Completion date
2026-09-01
Last updated
2025-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Suicide, Attempted

Brief summary

This is a Hybrid Type I Effectiveness-Implementation design. Specifically, this study proposes to test the effectiveness of STEP in reducing suicidal events and ideation in 216 adolescents, admitted to inpatient psychiatric care due to suicide risk. Participants will be randomized to either STEP or ETAU. STEP involves 4 in-person sessions (3 individual, 1 family) focused on psychoeducation regarding positive and negative affect, mindfulness meditation, gratitude, and savoring. Mood monitoring prompts and skill reminders will be sent daily for the first month post-discharge and three times a week for the following two months. The ETAU condition will receive reminders to log into a safety resource app, matched in frequency to the STEP group. Effectiveness aspects of the design include using clinical staff as interventionists and having very few exclusion criteria.

Detailed description

216 participants and their families (across two sites) will be randomized to either STEP or ETAU (as described in the research strategy). Aims and hypotheses are below: Aim 1: Examine the effectiveness of STEP in reducing suicidal events (attempt or emergency intervention to intercede attempt), active SI (with intent or plan), and depression at 6-month f/u (primary) and suicidal events at 12-month follow-up (f/u). H1: It is hypothesized that those randomized to STEP, compared to ETAU, will have lower rates of suicide events (H1A), active SI (H1B), and depression (H1C) over the 6-month follow-up period; H1D: It is hypothesized that those randomized to STEP, compared to ETAU, will have lower rates of suicidal events at the 12-month, long term f/u. Aim 2: Examine engagement of the hypothesized mechanisms at the 3- and 6-month f/u. It is hypothesized that those randomized to STEP, compared to ETAU, will have: H2A: higher attention to positive affect, assessed by implicit tasks; H2B: higher gratitude and satisfaction with life, assessed by self-report; H2C: lower negative affect, assessed by implicit tasks and self-report. Aim 3: Examine whether hypothesized mechanisms mediate reduction of suicidal events and ideation. H3: Changes in attention to positive affect, gratitude, satisfaction with life, and negative affect at 3-month f/u will be related to improvements in suicidal ideation and suicidal events at the 6-month f/u. Secondary Aim Examine elements supporting external validity. Acceptability, appropriateness, and feasibility of STEP to patients, parents, clinicians, and administrators will be assessed by: 1) a survey consisting of brief, standardized measures of these items, and 2) qualitative interviews to further explore these perceptions. These findings will be used to: 1) modify STEP to address potential barriers, and 2) develop implementation strategies designed to overcome these challenges, for testing in a future Hybrid Type III effectiveness-implementation trial.

Interventions

BEHAVIORALSTEP

Behavioral intervention to increase positive affect

BEHAVIORALEnhanced TAU

Standard care plus a phone app with a personalized safety plan

Sponsors

Brown University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The baseline assessment will occur prior to randomization and follow-up assessors will be blind to participant condition

Intervention model description

2 condition randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
12 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Patients * Ages 12- 60 years * hospitalized on an inpatient psychiatric unit due to suicide risk * past month suicide attempts or suicidal ideation * proficient in English (parent either English or Spanish * access to a smart phone. Inclusion Criteria: Stakeholders Ages 22 - 60 years * work with adolescents hospitalized on an inpatient psychiatric unit due to suicide risk * proficient in English or Spanish

Exclusion criteria

* active psychotic disorder * significant cognitive impairment or deficits * ward of the State * discharge to residential facility.

Design outcomes

Primary

MeasureTime frameDescription
Suicidal eventsbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upComposite variable of either a suicide attempt or emergency intervention to intercede when suicidal behavior may be imminent; Will be obtained from clinical interviews (C-SSRS; CASA) with the participant and parent(s).
Suicidal ideationbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upSuicide Ideation (SI) will be operationalized as proportion of participants with active SI as assessed by the Columbia Suicide Severity Rating Scale interview: 5 items on suicidal ideation rated yes or no
Proportion of Weeks with Suicidal ideationbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upThe proportion of weeks during follow-up with active suicidal ideation as assessed by the Adolescent version of the Longitudinal Interview for Follow-Up Events (A-LIFE) scale (interview based assessment), with the participant.
Depressionbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upDepressive symptom severity will be assessed using the Beck Depression Inventory II (BDI-II). The BDI-II will be administered to the adolescent participant and their parent (reporting on the adolescent participant) with scores ranging from 0 to 63 with higher scores reflecting greater depression.

Secondary

MeasureTime frameDescription
Gratitudebaseline; change from baseline at 3 months, 6 months, and 12 months follow-upGratitude will be assessed with the 6 item Gratitude Scale, administered to the participant only. Scores range from 6 to 42 with higher scores indicating greater gratitude.
Satisfaction with life scalebaseline; change from baseline at 3 months, 6 months, and 12 months follow-up5 self-report questions about participant satisfaction with life with scores ranging from 7 to 35 with higher scores indicating higher satisfaction with life.
Attention to positive affectbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upUsing eye tracking we will measure fixation and overall gaze duration during a dot probe task using emotional and neutral words to determine whether there is a change in attention to positive affect (participant only).
Implicit positive and negative affectbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upImplicit positive affect will be assessed using the Implicit Positive and Negative Affect Test (IPANAT), which is an indirect assessment of automatic activation of affective representations that utilizes artificial words paired with positive and negative words (participant only).
Explicit positive and negative affectbaseline; change from baseline at 3 months, 6 months, and 12 months follow-upExplicit positive affect will be assessed using the Modified Differential Emotions Scale (mDES) which is a 20 item short term self-report of positive and negative emotions administered to the participant only. There are 10 items in the positive affect and 10 items in the negative affect subscales with scores ranging from 0 to 30 for each subscale with higher scores reflecting higher affect.

Countries

United States

Contacts

Primary ContactAnthony Spirito, PhD
anthony_spirito@brown.edu4013692435
Backup ContactShirley Yen, PhD
shirley_yen@brown.edu4013787315

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026